Investment Type: Grant
Organization Type: Nonprofit
Medicines360 is a nonprofit pharmaceutical company that developed the hormonal IUD Liletta. Their mission is to expand access to affordable quality medicines for women regardless of their socioeconomic status, insurance coverage, or geographic location. Medicines360 believes that when women have choice around contraceptive access and availability, they can reach their full potential and so can families, businesses and communities around the globe. Medicines360 thinks cost should never stand between women and the medicines they need.
Why we invest:
We provided a restricted grant in 2018 to Medicines360 to explore the development of a new contraceptive delivery system that could dramatically expand access to women in need by enabling in-home access to effective contraception.